Clinical Trials Insight: 700028031

Trial Profile

Clinical Trials Insight: 700028031

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 03 Nov 2007

At a glance

  • Drugs HE 3286 (Primary)
  • Indications Insulin resistance; Obesity; Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Harbor Therapeutics
  • Most Recent Events

    • 03 Nov 2007 This trial is expected to be initiated in quarter 2 of 2008.
    • 01 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top